Aprea Therapeutics is a biotechnology business based in the US. Aprea Therapeutics shares (APRE) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy Aprea Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – APRE. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Aprea Therapeutics stock price (NASDAQ: APRE)
Use our graph to track the performance of APRE stocks over time.Aprea Therapeutics shares at a glance
Latest market close | $4.60 |
---|---|
52-week range | $0.47 - $40.80 |
50-day moving average | $7.77 |
200-day moving average | $12.73 |
Wall St. target price | $45.33 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-89.71 |
Buy Aprea Therapeutics stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Aprea Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aprea Therapeutics price performance over time
Historical closes compared with the close of $4.6 from 2023-03-24
1 week (2023-03-20) | -10.49% |
---|---|
1 month (2023-02-27) | -9.09% |
3 months (2022-12-27) | 1,213.91% |
6 months (2022-09-27) | 592.15% |
1 year (2022-03-23) | N/A |
---|---|
2 years (2021-03-26) | -9.80% |
3 years (2020-03-27) | 34.75 |
5 years (2018-03-23) | N/A |
Aprea Therapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -33.78% |
Return on equity TTM | -62.79% |
Profit margin | 0% |
Book value | $10.19 |
Market capitalisation | $19.2 million |
TTM: trailing 12 months
Aprea Therapeutics share dividends
We're not expecting Aprea Therapeutics to pay a dividend over the next 12 months.
Have Aprea Therapeutics's shares ever split?
Aprea Therapeutics's shares were split on a 1:20 basis on 12 February 2023. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aprea Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Aprea Therapeutics shares which in turn could have impacted Aprea Therapeutics's share price.
Aprea Therapeutics share price volatility
Over the last 12 months, Aprea Therapeutics's shares have ranged in value from as little as $0.474 up to $40.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aprea Therapeutics's is 0.1664. This would suggest that Aprea Therapeutics's shares are less volatile than average (for this exchange).
Aprea Therapeutics overview
Aprea Therapeutics, Inc. , a biopharmaceutical company, focuses on developing and commercializing synthetic lethality-based cancer therapeutics that target a critical pathway and various central targets in DNA damage response and cancer progression. Its lead program is ATRN-119, a clinical-stage small molecule ATR inhibitor being developed for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania. .
Aprea Therapeutics in the news
Aprea Therapeutics Announces Presentation of Preclinical Data on Pipeline Programs at the AACR 2023 Annual Meeting
Aprea Therapeutics to Present at Oppenheimer’s 33rd Annual Healthcare Conference
Aprea Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
Frequently asked questions
What percentage of Aprea Therapeutics is owned by insiders or institutions?Currently 16.362% of Aprea Therapeutics shares are held by insiders and 14.883% by institutions. When does the fiscal year end for Aprea Therapeutics?
Aprea Therapeutics's fiscal year ends in December. Where is Aprea Therapeutics based?
Aprea Therapeutics's address is: 535 Boylston St., Boston, MA, United States, 02116 What is Aprea Therapeutics's ISIN number?
Aprea Therapeutics's international securities identification number is: US03836J1025 What is Aprea Therapeutics's CUSIP number?
Aprea Therapeutics's Committee on Uniform Securities Identification Procedures number is: 03836J102
More guides on Finder
-
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
-
How to buy gold
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
-
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
-
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
-
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
Ask an Expert